Src family kinases and paclitaxel sensitivity

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Autophagy in the Pathogenesis of Disease

Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · see citing works

Microtubules as a target for anticancer drugs

Jordan, M. A., & Wilson, L. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1317 · Cited by 4,534 · see citing works

Promotion of microtubule assembly in vitro by taxol

SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600 · see citing works

Cellular functions regulated by Src family kinases.

Thomas, S. M., & Brugge, J. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,610 · see citing works

Taxol stabilizes microtubules in mouse fibroblast cells.

Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,971 · see citing works

SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins

Koch, C. A., Anderson, D. H., Moran, M. F., Ellis, C. A., & Pawson, T. J. (1991) · Science · doi:10.1126/science.1708916 · Cited by 1,868 · see citing works

Cell death by mitotic catastrophe: a molecular definition

Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269 · see citing works

The Double-Edged Sword of Autophagy Modulation in Cancer

White, E., & DiPaola, R. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5023 · Cited by 1,137 · see citing works

Microtubules and resistance to tubulin-binding agents

Kavallaris, M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2803 · Cited by 1,134 · see citing works

Identification of a transformation-specific antigen induced by an avian sarcoma virus

Brugge, J. S., & Erikson, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 889 · see citing works

Src family kinases in tumor progression and metastasis

Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827 · see citing works

Mechanisms of Taxol resistance related to microtubules

Orr, G. A., Verdier-Pinard, P., McDaid, H., & Horwitz, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206934 · Cited by 727 · see citing works

Src kinases as therapeutic targets for cancer

Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700 · see citing works

Mechanisms of Multidrug Resistance in Cancer

Gillet, J., & Gottesman, M. M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 696 · see citing works

Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization

Giannakakou, P., Sackett, D. L., Kang, Y., Zhan, Z., Buters, J., Fojo, T., & Poruchynsky, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17118 · Cited by 682 · see citing works

Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein

Levinson, A. D., Oppermann, H., Levintow, L., VARMUS, H. E., & Bishop, J. M. (1978) · Cell · doi:10.1016/0092-8674(78)90024-7 · Cited by 653 · see citing works

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., & Taraboletti, G. (1996) · PubMed · Cited by 643 · see citing works

Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross‐talk with estrogen receptor

Migliaccio, A., Piccolo, D., Castoria, G., Domenico, M. D., Bilancio, A., Lombardi, M., Gong, W., Beato, M., & Auricchio, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2008 · Cited by 627 · see citing works

c-Src and cooperating partners in human cancer

Ishizawar, R., & Parsons, S. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.001 · Cited by 617 · see citing works

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Kavallaris, M., Kuo, D. Y., Burkhart, C. A., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119642 · Cited by 605 · see citing works

Src kinase regulation by phosphorylation and dephosphorylation

Roskoski, R. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.012 · Cited by 577 · see citing works

Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death

Dumontet, C., & Sikic, B. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1061 · Cited by 572 · see citing works

Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells

Yvon, A.-M. C., Wadsworth, P., & Jordan, M. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.947 · Cited by 550 · see citing works

Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors

Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318549 · Cited by 479 · see citing works

Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors

Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18549 · Cited by 478 · see citing works

Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis

Weis, S. M., Cui, J., Barnes, L. A., & Cheresh, D. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477 · see citing works

The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells

Lü, Z., Luo, R. Z.-T., Lu, Y., Zhang, X., Yu, Q., Khare, S., Kondo, S., Kondo, Y., Yu, Y., Mills, G. B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35512 · Cited by 466 · see citing works

MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression

Zhou, M., Liu, Z., Zhao, Y., Ding, Y., Liu, H., Xi, Y., Xiong, W., Li, G., Lu, J., Fodstad, Ø., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083337 · Cited by 424 · see citing works

Taxol (paclitaxel): mechanisms of action.

Horwitz, S. B. (1994) · PubMed · Cited by 420 · see citing works

Taxol: Mechanisms of Action and Resistancea

Horwitz, S. B., Lothstein, L., Manfredi, J. J., et al. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb38455.x · Cited by 417 · see citing works

Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer

Rouzier, R., Rajan, R., Wagner, P., Hess, K. R., Gold, D. L., Stec, J. J., Ayers, M., Ross, J. S., Zhang, P. G. Y., Buchholz, T. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408974102 · Cited by 413 · see citing works

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro

Finn, R. S., Dering, J., Ginther, C., Wilson, C., Glaspy, P., Tchekmedyian, N., & Slamon, D. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9463-x · Cited by 410 · see citing works

Constitutive activation of Src family kinases in mouse embryos that lack Csk

Nada, S., Yagi, T., Takeda, H., Tokunaga, T., Nakagawa, H., Ikawa, Y., Okada, M., & Aizawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)90642-4 · Cited by 402 · see citing works

Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice

Imamoto, A., & Soriano, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90641-3 · Cited by 400 · see citing works

Microtubule dynamics in vitro are regulated by the tubulin isotype composition.

Panda, D., Miller, H. P., Banerjee, A., Ludueña, R. F., & Wilson, L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11358 · Cited by 372 · see citing works

Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis

Song, Z., Yao, X., & Wu, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300957200 · Cited by 364 · see citing works

The Role of Src in Solid Tumors

Wheeler, D. L., Iida, M., & Dunn, E. F. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0009 · Cited by 346 · see citing works

Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection

Huang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P., & Clark, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3633 · Cited by 344 · see citing works

Src family kinases: Regulation of their activities, levels and identification of new pathways

Ingley, E. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.012 · Cited by 337 · see citing works

Substoichiometric Binding of Taxol Suppresses Microtubule Dynamics

Derry, W. B., Wilson, L. R., & Jordan, M. A. (1995) · Biochemistry · doi:10.1021/bi00007a014 · Cited by 335 · see citing works

Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells

Johnson, F. M., Saigal, B., Talpaz, M., & Donato, N. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0757 · Cited by 330 · see citing works

Mitosis is not a key target of microtubule agents in patient tumors

Komlodi-Pasztor, E., Sackett, D., Wilkerson, J., & Fojo, T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.228 · Cited by 312 · see citing works

Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

Lens, S. M. A., Wolthuis, R. M. F., Klompmaker, R., Kauw, J., Agami, R., Brummelkamp, T. R., Kops, G. J. P. L., & Medema, R. H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg307 · Cited by 310 · see citing works

Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.

Ottenhoff-Kalff, A. E., Rijksen, G., van Beurden, E. A., Hennipman, A. H., Michels, A. A., & Staal, G. E. J. (1992) · PubMed · Cited by 306 · see citing works

Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories.Preprint

Lowell, C. A., & Soriano, P. M. (1996) · Genes & Development · doi:10.1101/gad.10.15.1845 · Cited by 285 · see citing works

The roles of copper transporters in cisplatin resistance

Kuo, M. T., Chen, H. H. W., Song, I., Savaraj, N., & Ishikawa, T. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9045-3 · Cited by 282 · see citing works

Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

Zaffaroni, N., Pennati, M., Colella, G., et al. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8518-3 · Cited by 276 · see citing works

CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration

Bourguignon, L., Zhu, H., Shao, L., & Chen, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006498200 · Cited by 262 · see citing works

Targeting Src in breast cancer

Finn, R. S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn291 · Cited by 248 · see citing works

The Extracellular Matrix Protein TGFBI Induces Microtubule Stabilization and Sensitizes Ovarian Cancers to Paclitaxel

Ahmed, A. A., Mills, A. D., Ibrahim, A. E. K., Temple, J., Blenkiron, C., Vias, M., Massie, C. E., Iyer, N. G., McGeoch, A. T., Crawford, R., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.014 · Cited by 233 · see citing works

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.

Muthuswamy, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.735 · Cited by 228 · see citing works

Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung Cancer

Gan, P. P., Pasquier, E., & Kavallaris, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0509 · Cited by 222 · see citing works

Taxol: mechanisms of action and resistance.

Horwitz, S. B., Cohen, D., Rao, S., et al. (1993) · PubMed · Cited by 220 · see citing works

SRC: A Century of Science Brought to the Clinic

Aleshin, A. A., & Finn, R. S. (2010) · Neoplasia · doi:10.1593/neo.10328 · Cited by 212 · see citing works

Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents

Fojo, T., & Menefee, M. E. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm172 · Cited by 212 · see citing works

Dasatinib (BMS-354825) Selectively Induces Apoptosis in Lung Cancer Cells Dependent on Epidermal Growth Factor Receptor Signaling for Survival

Song, L., Morris, M. D., Bagui, T. K., Lee, F. Y., Jove, R., & Haura, E. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4620 · Cited by 203 · see citing works

Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.Preprint

Guy, C. T., Muthuswamy, S. K., Cardiff, R. D., Soriano, P. M., & Muller, W. (1994) · Genes & Development · doi:10.1101/gad.8.1.23 · Cited by 202 · see citing works

Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

Alli, E., Bash-Babula, J., Yang, J., & Hait, W. N. (2002) · PubMed · Cited by 187 · see citing works

Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol

Kavallaris, M., Burkhart, C. A., & Horwitz, S. B. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690507 · Cited by 179 · see citing works

Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA

Vispé, S., DeVries, L., Créancier, L., Besse, J., Bréand, S., Hobson, D. J., Svejstrup, J. Q., Annereau, J., Cussac, D., Dumontet, C., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0549 · Cited by 177 · see citing works

Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest

Ling, X., Bernacki, R. J., Brattain, M. G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310947200 · Cited by 176 · see citing works

Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers

Wiener, J. R., Windham, T. C., Estrella, V. C., Parikh, N. U., Thall, P. F., Deavers, M. T., Bast, R. C., Mills, G. B., & Gallick, G. E. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6851 · Cited by 175 · see citing works

Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas.

Jacobs, C., & Rübsamen, H. (1983) · PubMed · Cited by 168 · see citing works

Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells

Zhang, Q. H., Thomas, S. M., Xi, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0504 · Cited by 167 · see citing works

SRC gene expression in human cancer: the role of transcriptional activation

Dehm, S. M., & Bonham, K. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-077 · Cited by 165 · see citing works

Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors

Wu, Z., Chang, P., Yang, J. C., Chu, C.-Y., Wang, L., Chen, N., Ma, A.-H., Desai, S. J., Lo, S. H., Evans, C. P., et al. (2010) · Genes & Cancer · doi:10.1177/1947601909358324 · Cited by 165 · see citing works

β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis

Rosanò, L., Cianfrocca, R., Masi, S., Spinella, F., Castro, V. D., Biroccio, A., Salvati, E., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807158106 · Cited by 163 · see citing works

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples

Penson, R. T., Oliva, E., Skates, S. J., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.053 · Cited by 163 · see citing works

Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation.

Martello, L. A., Verdier‐Pinard, P., Shen, H. J., He, L., Torres, K. E., Orr, G. A., & Horwitz, S. B. (2003) · PubMed · Cited by 160 · see citing works

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy

Wen, X.-F., Yang, G. S., Mao, W., Thornton, A., Liu, J., Bast, R. C., & Le, X.-F. (2006) · Oncogene · doi:10.1038/sj.onc.1209685 · Cited by 159 · see citing works

Stress Hormones Regulate Interleukin-6 Expression by Human Ovarian Carcinoma Cells through a Src-dependent Mechanism

Nilsson, M. B., Armaiz-Peña, G. N., Takahashi, R., Lin, Y. G., Trevino, J. G., Li, Y., Jennings, N., Arevalo, J. M. G., Lutgendorf, S. K., Gallick, G. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611539200 · Cited by 158 · see citing works

The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells

Zhang, C. C., Yang, J., White, E., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201658 · Cited by 158 · see citing works

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines

Zhang, J., Kalyankrishna, S., Wislez, M., Thilaganathan, N., Saigal, B., Wei, W., Ma, L., Wistuba, I. I., Johnson, F. M., & Kurie, J. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060706 · Cited by 154 · see citing works

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Mangala, L. S., Zuzel, V., Schmandt, R. E., LeShane, E. S., Halder, J. B., Armaiz-Peña, G. N., Spannuth, W. A., Tanaka, T., Shahzad, M. M. K., Lin, Y. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2306 · Cited by 154 · see citing works

Clinical Overview of the Taxanes

Goldspiel, B. R. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03813.x · Cited by 146 · see citing works

p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.

Debernardis, D., Siré, E. G., de Feudis, P., Vikhanskaya, F., Valenti, M., Russo, P., Parodi, S., D’Incalci, M., & Broggini, M. (1997) · PubMed · Cited by 146 · see citing works

A β-Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance

Gonzalez‐Garay, M. L., Chang, L., Cabral, F., Blade, K. L., & Menick, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23875 · Cited by 146 · see citing works

Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer

Landen, C. N., Lu, C., Han, L. Y., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj414 · Cited by 134 · see citing works

FYB (FYN binding protein) serves as a binding partner for lymphoid protein and FYN kinase substrate SKAP55 and a SKAP55-related protein in T cells

Liu, J., Kang, H. K., Raab, M., da Silva, A. J., Kraeft, S., & Rudd, C. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8779 · Cited by 133 · see citing works

Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies

Ahluwalia, M. S., de Groot, J., Liu, W., & Gladson, C. L. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.08.014 · Cited by 128 · see citing works

Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma

Milano, V. C., Piao, Y., LaFortune, T. A., & de Groot, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0669 · Cited by 127 · see citing works

Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib

Serrels, A., Macpherson, I. R., Evans, T. R. J., Lee, F. Y., Clark, E. A., Sansom, O. J., Ashton, G. H. S., Frame, M. C., & Brunton, V. G. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0382 · Cited by 124 · see citing works

Transmembrane Signaling by G Protein-Coupled Receptors

Luttrell, L. M. (2006) · Humana Press eBooks · doi:10.1385/1-59745-048-0:1 · Cited by 123 · see citing works

Src redox regulation: Again in the front line

Giannoni, E., Taddei, M. L., & Chiarugi, P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.025 · Cited by 121 · see citing works

Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma

Brooks, H. D., Glisson, B. S., Bekele, B. N., Ginsberg, L. E., El‐Naggar, A. K., Culotta, K. S., Takebe, N., Wright, J., Tran, H. T., & Papadimitrakopoulou, V. A. (2010) · Cancer · doi:10.1002/cncr.25769 · Cited by 117 · see citing works

The Lipid Raft-Anchored Adaptor Protein Cbp Controls the Oncogenic Potential of c-Src

Oneyama, C., Hikita, T., Enya, K., Dobenecker, M.-W., Saito, K., Nada, S., Tarakhovsky, A., & Okada, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.026 · Cited by 116 · see citing works

Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma

Koppikar, P., Choi, S.-H., Egloff, A. M., Cai, Q., Suzuki, S., Freilino, M. L., Nozawa, H., Thomas, S. M., Gooding, W. E., Siegfried, J. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5226 · Cited by 113 · see citing works

pp60c-src activation in lung adenocarcinoma

Masaki, T., Igarashi, K., Tokuda, M., Yukimasa, S., Han, F., Jin, Y. J., Li, J. Q., Yoneyama, H., Uchida, N., Fujita, J., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00276-4 · Cited by 111 · see citing works

Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells

Nam, S., Williams, A. H., Vultur, A., List, A. F., Bhalla, K. N., Smith, D. D., Lee, F. Y., & Jove, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0446 · Cited by 109 · see citing works

Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell line

Pengetnze, Y., Steed, M., Roby, K. F., Terranova, P. F., & Taylor, C. C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.012 · Cited by 107 · see citing works

ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis

Tan, M., Li, P., Klos, K. S., Lü, J., Lan, K., Nagata, Y., Fang, D., Jing, T., & Yu, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2353 · Cited by 107 · see citing works

Human Mutations That Confer Paclitaxel Resistance

Yin, S., Bhattacharya, R., & Cabral, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0674 · Cited by 103 · see citing works

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells

Konecny, G. E., Glas, R., Dering, J., Manivong, K., Qi, J., Finn, R. S., Yang, G. R., Hong, K.-L., Ginther, C., Winterhoff, B. J. N., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605381 · Cited by 101 · see citing works

The Tensin-3 Protein, Including its SH2 Domain, Is Phosphorylated by Src and Contributes to Tumorigenesis and Metastasis

Qian, X., Li, G., Vass, W. C., Papageorge, A. G., Walker, R. C., Asnaghi, L., Steinbach, P. J., Tosato, G., Hunter, K. W., & Lowy, D. R. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.031 · Cited by 99 · see citing works

Src as a potential therapeutic target in non-small-cell lung cancer

Giaccone, G., & Zucali, P. A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn048 · Cited by 99 · see citing works

Src Family Nonreceptor Tyrosine Kinases as Molecular Targets for Cancer Therapy

Johnson, F. M., & Gallick, G. E. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007784111278 · Cited by 98 · see citing works

Modulation of the SH2 Binding Specificity and Kinase Activity of Src by Tyrosine Phosphorylation within Its SH2 Domain

Stover, D. R., Furet, P., & Lydon, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12481 · Cited by 95 · see citing works

Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin

Gan, P. P., McCarroll, J. A., Po’uha, S. T., Kamath, K., Jordan, M. A., & Kavallaris, M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0679 · Cited by 95 · see citing works

Targeting Epidermal Growth Factor Receptor and Src Pathways in Head and Neck Cancer

Egloff, A. M., & Grandis, J. R. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.03.008 · Cited by 94 · see citing works

Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian Carcinoma

Han, L. Y., Landen, C. N., Trevino, J. G., Halder, J., Lin, Y. G., Kamat, A. A., Kim, T., Merritt, W. M., Coleman, R. L., Gershenson, D. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1410 · Cited by 94 · see citing works

Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3

Chen, T., Pengetnze, Y., & Taylor, C. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.217.4.2 · Cited by 94 · see citing works

Caveolin Scaffolding Region and the Membrane Binding Region of Src Form Lateral Membrane Domains

Wanaski, S. P., Ng, B. K., & Gläser, M. (2002) · Biochemistry · doi:10.1021/bi012097n · Cited by 93 · see citing works

Phosphorylation of c-Src on Tyrosine 527 by Another Protein Tyrosine Kinase

Thomas, J. E., Soriano, P. M., & Brugge, J. S. (1991) · Science · doi:10.1126/science.1719633 · Cited by 92 · see citing works

Dasatinib induces autophagic cell death in human ovarian cancer

Le, X., Mao, W., Lü, Z., Carter, B. Z., & Bast, R. C. (2010) · Cancer · doi:10.1002/cncr.25426 · Cited by 92 · see citing works

Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.

Wiener, J. R., Nakano, K., Kruzelock, R. P., Bucana, C. D., Bast, R. C., & Gallick, G. E. (1999) · PubMed · Cited by 91 · see citing works

Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial

Pusztai, L., Jeong, J., Gong, Y. Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6887 · Cited by 90 · see citing works

Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling

Cantiani, L., Manara, M. C., Zucchini, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4697 · Cited by 88 · see citing works

Regulated Association of Microtubule-associated Protein 2 (MAP2) with Src and Grb2: Evidence for MAP2 as a Scaffolding Protein

Lim, R. W. L., & Halpain, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001887200 · Cited by 86 · see citing works

Prognostic relevance of P-glycoprotein expression in breast cancer

Linn, S. C., Giaccone, G., van Diest, P. J., et al. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059284 · Cited by 83 · see citing works

Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring

Wang, X.-D., Reeves, K. A., Luo, F. R., Xu, L., Lee, F. Y., Clark, E. A., & Huang, F. (2007) · Genome biology · doi:10.1186/gb-2007-8-11-r255 · Cited by 82 · see citing works

Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Teneriello, M. G., Tseng, P. C., Crozier, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9548 · Cited by 80 · see citing works

Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers.

Šale, S., Sung, R. K., Shen, P., et al. (2002) · PubMed · Cited by 79 · see citing works

Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel

Zou, C., Jia, L., Jin, H., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-22 · Cited by 79 · see citing works

Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance

Lü, J., Tan, M., Huang, W.-C., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0954 · Cited by 79 · see citing works

SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells

George, J. A., Chen, T., & Taylor, C. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1822 · Cited by 78 · see citing works

MRP7/ABCC10expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer

Oguri, T., Ozasa, H., Uemura, T., Bessho, Y., Miyazaki, M., Maeno, K., 前田, 浩., Sato, S., & Ueda, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2088 · Cited by 76 · see citing works

Activity of pp60c-src in 60 different cell lines derived from human tumors.

Budde, R. J. A., Ke, S., & Levin, V. A. (1994) · PubMed · Cited by 76 · see citing works

Signalling by the p60 family of protein—tyrosine kinases

Kefalas, P., Brown, T. R. P., & Brickell, P. M. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00024-j · Cited by 75 · see citing works

Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models

Lu, C., Shahzad, M. M. K., Moreno‐Smith, M., Lin, Y. G., Jennings, N. B., Allen, J. K., Landen, C. N., Mangala, L. S., Armaiz-Peña, G. N., Schmandt, R. E., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.10635 · Cited by 75 · see citing works

Functional Roles of Src and Fgr in Ovarian Carcinoma

Kim, H., Han, H. D., Armaiz-Peña, G. N., Stone, R. L., Nam, E. J., Lee, J., Shahzad, M. M. K., Nick, A. M., Lee, S. J., Roh, J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2081 · Cited by 75 · see citing works

Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers

Cheung, C. H. A., Chen, H.-H., Kuo, C., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-43 · Cited by 75 · see citing works

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity

Wilson, G., Cramer, A., Welman, A., Knox, F., Swindell, R., Kawakatsu, H., Clarke, R. B., Dive, C., & Bundred, N. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603444 · Cited by 74 · see citing works

Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer

Matsuoka (1992) · International Journal of Oncology · doi:10.3892/ijo_00000153 · Cited by 74 · see citing works

Transforming Growth Factor-β1-dependent Urokinase Up-regulation and Promotion of Invasion Are Involved in Src-MAPK-dependent Signaling in Human Ovarian Cancer Cells

Tanaka, Y., Kobayashi, H., Suzuki, M., Kanayama, N., & Terao, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309131200 · Cited by 74 · see citing works

Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential

Semba, S., Trapasso, F., Fabbri, M., McCorkell, K. A., Volinia, S., Druck, T., Iliopoulos, D., Pekarsky, Y., Ishii, H., Garrison, P. N., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209323 · Cited by 73 · see citing works

Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin‐based chemotherapy

Martinez‐Balibrea, E., Martínez‐Cardús, A., Musulén, E., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24273 · Cited by 73 · see citing works

Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport

Furukawa, T., Komatsu, M., Ikeda, R., et al. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786848479 · Cited by 71 · see citing works

Caveolin-1 Tyrosine Phosphorylation Enhances Paclitaxel-mediated Cytotoxicity

Shajahan‐Haq, A. N., Wang, A., Decker, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608857200 · Cited by 70 · see citing works

Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression

Elsberger, B., Fullerton, R., Zino, S., Jordan, F., Mitchell, T. J., Brunton, V. G., Mallon, E., Shiels, P. G., & Edwards, J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605829 · Cited by 70 · see citing works

Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.

Iancu, C., Mistry, S. J., Arkin, S., et al. (2000) · PubMed · Cited by 68 · see citing works

Copper-Transporting P-Type ATPase, ATP7A, Confers Multidrug Resistance and Its Expression Is Related to Resistance to SN-38 in Clinical Colon Cancer

Owatari, S., Akune, S., Komatsu, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3096 · Cited by 65 · see citing works

Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2

Le, X., Mao, W., Lu, C., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.23.7212 · Cited by 65 · see citing works

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

Fornier, M. N., Morris, P. G., Abbruzzi, A., D’Andrea, G. M., Gilewski, T., Bromberg, J., Dang, C. T., Dickler, M. N., Modi, S., Seidman, A. D., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr018 · Cited by 64 · see citing works

The Tumor Suppressor Protein Fhit

Chaudhuri, A. R., KHAN, I. A., Prasad, V., Robinson, A. K., Ludueña, R. F., & Barnes, L. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24378 · Cited by 63 · see citing works

Dual targeting of EphA2 and FAK in ovarian carcinoma

Shahzad, M. M. K., Lu, C., Lee, J.-W., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8523 · Cited by 63 · see citing works

Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis

Griffiths, G. J., Koh, M. Y., Brunton, V. G., Cawthorne, C., Reeves, N. A., Greaves, M., Tilby, M. J., Pearson, D. G., Ottley, C. J., Workman, P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408550200 · Cited by 60 · see citing works

Src Inhibitors in Lung Cancer: Current Status and Future Directions

Rothschild, S. I., Gautschi, O. P., Haura, E. B., & Johnson, F. M. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.030 · Cited by 59 · see citing works

Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells

Jeong, K. J., Park, S. Y., Seo, J. H., et al. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.6.607 · Cited by 58 · see citing works

Larotaxel: broadening the road with new taxanes

Metzger, O., Moulin, C., de Azambuja, E., & Awada, A. H. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903119167 · Cited by 57 · see citing works

Mutational analysis of the class I β‐tubulin gene in human breast cancer

Hasegawa, S., Miyoshi, Y., Egawa, C., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10575 · Cited by 57 · see citing works

Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders

Oijen, M. G. C. T., Rijksen, G., ten Broek, F.-W., & Slootweg, P. J. (2007) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1998.tb01931.x · Cited by 56 · see citing works

Cdc2-mediated modulation of pp60c-src activity.

Stover, D. R., Liebetanz, J., & Lydon, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47102-5 · Cited by 53 · see citing works

Mutational analysis of the β-tubulin gene in lung cancer

Tsurutani, J., Komiya, T., Uejima, H., et al. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00291-4 · Cited by 49 · see citing works

Src Promotes Survival and Invasion of Lung Cancers with Epidermal Growth Factor Receptor Abnormalities and Is a Potential Candidate for Molecular-Targeted Therapy

Leung, E. L., Tam, I. Y. S., Tin, V. P., Chua, D. T.-T., Sihoe, A. D., Cheng, L., Ho, J., Chung, L.-P., & Wong, M. P. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0003 · Cited by 48 · see citing works

Role of PELP1/MNAR Signaling in Ovarian Tumorigenesis

Chakravarty, D., Nair, S. S., Rajhans, R., Pitcheswara, P. R., Liu, J., Balasenthil, S., Le, X., Burow, M. E., Auersperg, N., TEKMAL, R. R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5698 · Cited by 48 · see citing works

C-Src Activation by ErbB2 Leads to Attachment-Independent Growth of Human Breast Epithelial Cells

Sheffield, L. G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9214 · Cited by 46 · see citing works

Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models

Lee, F. Y. F., Covello, K. L., Castaneda, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0025 · Cited by 43 · see citing works

Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines

Naramoto, H., Uematsu, T., Uchihashi, T., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.2.393 · Cited by 41 · see citing works

DIFFERENTIAL GROWTH OF N- AND S-TYPE HUMAN NEUROBLASTOMA CELLS XENOGRAFTED INTO SCID MICE. CORRELATION WITH APOPTOSIS

Piacentini, M., Piredda, L., Starace, D., Annicchiarico‐Petruzzelli, M., Mattei, M., Oliverio, S., Farrace, M. G., & Melino, G. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199612)180:4 · Cited by 39 · see citing works

Clinical Development of Src Tyrosine Kinase Inhibitors in Lung Cancer

Lee, D. L., & Gautschi, O. P. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.020 · Cited by 37 · see citing works

Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells

Teoh, D. K., Ayeni, T. A., Rubatt, J. M., Adams, D. J., Grace, L. A., Starr, M. D., Barry, W. T., Berchuck, A., Murphy, S. K., & Secord, A. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.11.017 · Cited by 37 · see citing works

Src inhibitors in breast cancer therapy

Hiscox, S., & Nicholson, R. I. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.757 · Cited by 37 · see citing works

The involvement of Fyn kinase in resumption of the first meiotic division in mouse oocytes

Levi, M., Maro, B., & Shalgi, R. (2010) · Cell Cycle · doi:10.4161/cc.9.8.11299 · Cited by 35 · see citing works

Grp94 is Tyr-phosphorylated by Fyn in the lumen of the endoplasmic reticulum and translocates to Golgi in differentiating myoblasts

Frasson, M., Vitadello, M., Brunati, A. M., Rocca, N. L., Tibaldi, E. V., Pinna, L. A., Gorza, L., & Donella‐Deana, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.10.001 · Cited by 34 · see citing works

Non-anti-mitotic concentrations of taxol reduce breast cancer cell invasiveness

Tran, T.-A., Gillet, L., Roger, S., Besson, P., White, E., & Guennec, J. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.073 · Cited by 33 · see citing works

Wild-type class I β-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a β-tubulin mutation

Wiesen, K. M., Xia, S., Yang, C. H., & Horwitz, S. B. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.07.022 · Cited by 32 · see citing works

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells

Hage‐Sleiman, R., Herveau, S., Matera, E., Laurier, J.-F., & Dumontet, C. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-135 · Cited by 28 · see citing works

Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120‐catenin

Huang, R. Y., Wang, S., Hsieh, C., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23579 · Cited by 27 · see citing works

FHIT protein enhances paclitaxel‐induced apoptosis in lung cancer cells

Kim, C. H., Yoo, J. S., Lee, C., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21573 · Cited by 22 · see citing works

The role of Fyn kinase in the release from metaphase in mammalian oocytes

Levi, M., & Shalgi, R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.027 · Cited by 20 · see citing works

Welcome

Pinedo, H. M. (1994) · Annals of Oncology · doi:10.1093/annonc/5.suppl_5.3 · Cited by 20 · see citing works

Src Tyrosine Kinase Inhibitor, M475271, Suppresses Subcutaneous Growth and Production of Lung Metastasis Via Inhibition of Proliferation, Invasion, and Vascularization of Human Lung Adenocarcinoma Cells

Zheng, R., Yano, S., Matsumori, Y., Nakataki, E., Muguruma, H., Yoshizumi, M., & Sone, S. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-7768-5 · Cited by 19 · see citing works

Amino acid substitutions at proline 220 of β-tubulin confer resistance to paclitaxel and colcemid

Yin, S., Cabral, F., & Veeraraghavan, S. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0791 · Cited by 19 · see citing works

Src as a Therapeutic Target in Breast Cancer

Morgan, L. D., Nicholson, R. I., & Hiscox, S. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008786848295 · Cited by 19 · see citing works

Suppression of Urokinase Expression and Invasion by a Soybean Kunitz Trypsin Inhibitor Are Mediated through Inhibition of Src-dependent Signaling Pathways

Inagaki, K., Kobayashi, H., Yoshida, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501406200 · Cited by 18 · see citing works

Fyn Phosphorylates Human MAP-2c on Tyrosine 67

Zamora-León, S. P., Bresnick, A. R., Backer, J., & Shafit‐Zagardo, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411380200 · Cited by 16 · see citing works

Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity.

Bellarosa, D., Binaschi, M., Maggi, C. A., & Goso, C. (2005) · PubMed · Cited by 16 · see citing works

Transforming growth factor‐β1‐dependent activation of Smad2/3 and up‐regulation of PAI‐1 expression is negatively regulated by Src in SKOV‐3 human ovarian cancer cells

Wakahara, K., Kobayashi, H., Yagyu, T., et al. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20160 · Cited by 15 · see citing works

Effect of autophagy on paclitaxel-induced CaSki cell death.

Sun, Y., Jin, L. G., Liu, J., et al. (2010) · PubMed · doi:10.3969/j.issn.1672-7347.2010.06.004 · Cited by 12 · see citing works

Abundant expression of the microtubule‐associated protein, ensconsin (E‐MAP‐115), alters the cellular response to Taxol

Gruber, D., Faire, K., & Bulinski, J. C. (2001) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.1026 · Cited by 11 · see citing works

[The detection of the c-src protein gene product in human lung tumors].

Мазуренко, Н. Н., Коган, Е. А., Зборовская, И. Б., et al. (1991) · PubMed · Cited by 6 · see citing works

Genomic structure and alternative splicing of the murine bhk/ctk/ntk gene

Ershler, M. A., Samokhvalov, I. M., Belyavsky, A. V., et al. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01154-7 · Cited by 3 · see citing works

Mechanisms of Taxane Resistance

Maloney, S., Spring, C., Morejon-Lasso, L., & Prosperi, J. (2020) · Cancers · doi:10.3390/cancers12113323 · Cited by 198 · see citing works

Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells

Simpkins, F., Jang, K., Yoon, H., Hew, K. E., Kim, M., Azzam, D. J., Sun, J., Zhao, D., Ince, T. A., Liu, W., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3697 · Cited by 67 · see citing works

Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Perez, M., Lucena-Cacace, A., Marín-Gómez, L. M., Padillo-Ruiz, J., Robles-Frias, M. J., Saez, C., Garcia-Carbonero, R., & Carnero, A. (2016) · Oncotarget · doi:10.18632/oncotarget.8880 · Cited by 34 · see citing works

Autophagy in cancer biology and therapy

Noor, N., Gammoh, Simon, 。., et al. (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni

Is Selective Autophagy Distinct from Starvation-Induced Autophagy?

Guillebaud, G., & Germain, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802937-4.00005-3

Death and survival of neuronal and astrocytic cells in ischemic brain injury： a role of autophagy

Min, Xü, Huiling, et al. (2011) · 中国药理学报：英文版 · Cited by 1 · see citing works

Roles of autophagy in lymphocytes： reflections and directions

Ian, I., McLeod, You-wen, et al. (2010) · 中国免疫学杂志：英文版 · Cited by 1 · see citing works

Autophagy and cardiovascular diseases

Don, L. (2013) · International Journal of Pathology and Clinical Medicine